Clearmind Medicine Inc. Common Shares (CMND) Stock Analysis

Clearmind Medicine Inc. Common Shares (CMND) is a publicly traded company in the HEALTHCARE sector. It trades at $2.92, carries a market capitalization of $3.23M. This page summarizes the public market data, fundamentals, and frequently asked questions for CMND, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.92
• Market Cap: $3.23M
• EPS: $-241.20
• 52-Week High: $524.00
• 52-Week Low: $2.10

Market Sentiment

Clearmind Medicine Inc. Common Shares currently has a Bullish sentiment score of 0.57.

About Clearmind Medicine Inc. Common Shares

Clearmind Medicine Inc. (CMND) is an innovative preclinical pharmaceutical company based in Vancouver, Canada, specializing in the development of groundbreaking psychedelic therapies to address significant unmet medical needs in mental health. By focusing on neglected health challenges, Clearmind aims to pioneer research into psychedelic compounds that could enhance existing treatment models. The company's comprehensive pipeline underscores its dedication to advancing novel therapeutic soluti...

GNG Research Analysis

GNG Research scores Clearmind Medicine Inc. Common Shares (CMND) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CMND.

Frequently Asked Questions

Does CMND pay dividends?

Clearmind Medicine Inc. Common Shares (CMND) does not currently pay a regular dividend.

What is CMND's market cap?

Clearmind Medicine Inc. Common Shares (CMND) has a market capitalization of $3.23M with a current stock price of $2.92.